The challenge of methicillin resistant staphylococcal infection after total hip replacement: overlooked or overstated?

Bone Joint J. 2014 Nov;96-B(11 Supple A):60-5. doi: 10.1302/0301-620X.96B11.34333.

Abstract

Advances in the treatment of periprosthetic joint infections of the hip have once more pushed prosthesis preserving techniques into the limelight. At the same time, the common infecting organisms are evolving to become more resistant to conventional antimicrobial agents. Whilst the epidemiology of resistant staphylococci is changing, a number of recent reports have advocated the use of irrigation and debridement and one-stage revision for the treatment of periprosthetic joint infections due to resistant organisms. This review presents the available evidence for the treatment of periprosthetic joint infections of the hip, concentrating in particular on methicillin resistant staphylococci.

Keywords: Hip; MRSA; Periprosthetic Joint Infection; Two-stage revision.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Arthroplasty, Replacement, Hip / adverse effects*
  • Global Health
  • Humans
  • Incidence
  • Methicillin Resistance*
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification*
  • Prosthesis-Related Infections* / drug therapy
  • Prosthesis-Related Infections* / epidemiology
  • Prosthesis-Related Infections* / microbiology
  • Staphylococcal Infections* / drug therapy
  • Staphylococcal Infections* / epidemiology
  • Staphylococcal Infections* / microbiology

Substances

  • Anti-Bacterial Agents